{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/ESPR/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:58:50.788Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":794,"canonical_name":"Esperion Therapeutics, Inc.","cik":"0001434868","uei":null,"lei":null,"duns":null,"ticker":"ESPR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"fda":1,"sec":73,"open":1},"count":75,"timeline":[{"ts":"20260115","kind":"fda.label","reporter":"Esperion Therapeutics, Inc.","title":"Nexletol","security_title":"BEMPEDOIC ACID","excerpt":"1 INDICATIONS AND USAGE NEXLETOL is indicated: to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or coronary revascularization) in adults ","accession_number":"88d06d89-a3da-40b4-b273-8f4f7d56c4c9","route":"ORAL","product_type":"HUMAN PRESCRIPTION DRUG","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002301","accession_number":"9999999995-26-002301","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002302","accession_number":"9999999995-26-002302","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002303","accession_number":"9999999995-26-002303","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002304","accession_number":"9999999995-26-002304","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002305","accession_number":"9999999995-26-002305","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Esperion Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001434868/effect/9999999995-26-002307","accession_number":"9999999995-26-002307","importance":30},{"ts":"2026-07-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Esperion Therapeutics, Inc. — 2026-07-14","url_slug":"/sec/cik-0001434868/schedule-13g-a/0000814133-26-000078","accession_number":"0000814133-26-000078","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/8-k/0001104659-26-082926","accession_number":"0001104659-26-082926","importance":35},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Hoffman Robert E. — 2026-07-13","url_slug":"/sec/cik-0001166288/4/0001628280-26-048014","accession_number":"0001628280-26-048014","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048000","accession_number":"0001628280-26-048000","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048001","accession_number":"0001628280-26-048001","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048003","accession_number":"0001628280-26-048003","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048006","accession_number":"0001628280-26-048006","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048007","accession_number":"0001628280-26-048007","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/4/0001628280-26-048010","accession_number":"0001628280-26-048010","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083008","accession_number":"0001104659-26-083008","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083009","accession_number":"0001104659-26-083009","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083010","accession_number":"0001104659-26-083010","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083012","accession_number":"0001104659-26-083012","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083013","accession_number":"0001104659-26-083013","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS AM","title":"POS AM — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos-am/0001104659-26-083007","accession_number":"0001104659-26-083007","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POS462B","title":"POS462B — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/pos462b/0001104659-26-083011","accession_number":"0001104659-26-083011","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"POSASR","title":"POSASR — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/posasr/0001104659-26-083014","accession_number":"0001104659-26-083014","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082986","accession_number":"0001104659-26-082986","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082987","accession_number":"0001104659-26-082987","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082988","accession_number":"0001104659-26-082988","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082989","accession_number":"0001104659-26-082989","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082990","accession_number":"0001104659-26-082990","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082991","accession_number":"0001104659-26-082991","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082992","accession_number":"0001104659-26-082992","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082993","accession_number":"0001104659-26-082993","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082995","accession_number":"0001104659-26-082995","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082996","accession_number":"0001104659-26-082996","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082998","accession_number":"0001104659-26-082998","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-082999","accession_number":"0001104659-26-082999","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Esperion Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001434868/s-8-pos/0001104659-26-083001","accession_number":"0001104659-26-083001","importance":30},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Hoffman Robert E.","title":null,"shares":85153,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"CARROLL J MARTIN","title":null,"shares":177523,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Koenig Sheldon L.","title":"President and CEO","shares":2121094,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Looker Benjamin","title":"Chief Legal Officer","shares":667524,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Halladay Benjamin","title":"Chief Financial Officer","shares":705410,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Harlow John B. Jr.","title":"Chief Commercial Officer","shares":424536,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"THOMPSON JOHN CRAIG","title":null,"shares":79873,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Shepard Jay","title":"","shares":164472,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-13","kind":"sec.insider.d","reporter":"Fischer Seth H. Z.","title":null,"shares":141023,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Esperion Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001434868/8-k/0001104659-26-081588","accession_number":"0001104659-26-081588","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001434868/4/0001628280-26-044264","accession_number":"0001628280-26-044264","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001434868/4/0001628280-26-044266","accession_number":"0001628280-26-044266","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001434868/4/0001628280-26-044269","accession_number":"0001628280-26-044269","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Esperion Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001434868/8-k-a/0001628280-26-044260","accession_number":"0001628280-26-044260","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Koenig Sheldon L.","title":"Officer, Director","shares":53588,"usd_value":169059,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001959173-26-004750","importance":40.033811884},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Looker Benjamin","title":"Officer","shares":11824,"usd_value":37301,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001959173-26-004744","importance":40.007460236},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Halladay Benjamin","title":"Officer","shares":10773,"usd_value":33986,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001959173-26-004747","importance":40.006797118},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Koenig Sheldon L.","title":"President and CEO","shares":53588,"price_per_share":3.155,"usd_value":169070,"security_title":"Common Stock","importance":35.16907014},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Looker Benjamin","title":"Chief Legal Officer","shares":11824,"price_per_share":3.155,"usd_value":37305,"security_title":"Common Stock","importance":35.03730472},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Halladay Benjamin","title":"Chief Financial Officer","shares":10773,"price_per_share":3.155,"usd_value":33989,"security_title":"Common Stock","importance":35.033988815},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Esperion Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001434868/144/0001959173-26-004744","accession_number":"0001959173-26-004744","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Esperion Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001434868/144/0001959173-26-004747","accession_number":"0001959173-26-004747","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Esperion Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001434868/144/0001959173-26-004750","accession_number":"0001959173-26-004750","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Esperion Therapeutics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001434868/8-k/0001104659-26-074558","accession_number":"0001104659-26-074558","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Esperion Therapeutics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001434868/defa14a/0001104659-26-074562","accession_number":"0001104659-26-074562","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Esperion Therapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001434868/8-k/0001104659-26-071814","accession_number":"0001104659-26-071814","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"DEFM14A","title":"DEFM14A — Esperion Therapeutics, Inc. — 2026-06-08","url_slug":"/sec/cik-0001434868/defm14a/0001104659-26-071107","accession_number":"0001104659-26-071107","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Esperion Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001434868/8-k/0001628280-26-039518","accession_number":"0001628280-26-039518","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001434868/4/0001628280-26-039523","accession_number":"0001628280-26-039523","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001434868/4/0001628280-26-039526","accession_number":"0001628280-26-039526","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Esperion Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001434868/4/0001628280-26-039529","accession_number":"0001628280-26-039529","importance":30},{"ts":"2026-05-28","kind":"sec.insider.a","reporter":"Hoffman Robert E.","title":null,"shares":79873,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.a","reporter":"CARROLL J MARTIN","title":null,"shares":79873,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.a","reporter":"Fischer Seth H. Z.","title":null,"shares":79873,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.a","reporter":"Shepard Jay","title":"","shares":79873,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-28","kind":"sec.insider.a","reporter":"THOMPSON JOHN CRAIG","title":null,"shares":79873,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Esperion Therapeutics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001434868/10-q/0001628280-26-032870","accession_number":"0001628280-26-032870","importance":45},{"ts":"2024-12-31","kind":"open.payments","reporter":"Esperion Therapeutics, Inc.","title":"$1314965.0 to 13427 physicians (2024–2024)","security_title":"manufacturer","excerpt":"NEXLIZET","accession_number":"2024","usd_value":1314965,"importance":70}]}